-
REPORTIndustry Profile 2022
To download the full report, click here.
The Profile is PhRMA’s flagship publication for telling the story of the sector for nearly five decades. It outlines what the industry stands for—including key policy solutions—along with an advocacy toolkit on key issue areas.
Scroll below to see additional resources available in this year's advocacy toolkit.
2022 Industry Toolkits
2022 Industry Profile Toolkit: About PhRMA
2022 Industry Profile Toolkit: Medicines are Transforming the Trajectory of Many Diseases
2022 Industry Profile Toolkit: The Biopharmaceutical Industry’s Role in Fueling the U.S. Economy and Global Competitiveness
2022 Industry Profile Toolkit: The Dynamic U.S. Research and Development Ecosystem
2022 Industry Profile Toolkit: Better Use of Medicines Can Improve Health Outcomes and Reduce the Use of Costly Medical Care
2022 Industry Profile Toolkit: 10 Things You Should Know About Medicine Spending and Costs
2022 Industry Profile Toolkit: The Importance of Strong Trade Policy in Driving Biopharmaceutical Innovation
2022 Industry Profile Toolkit: Innovative Contracting Opportunities and challenges
2022 Industry Profile Toolkit: The Biopharmaceutical Industry’s Commitment to Building a More Resilient Health Care System
2022 Industry Profile Toolkit Addressing a Growing Public Health Emergency Antimicrobial Resistance
2022 Industry Profile Toolkit: How the U.S. Health Care System Can Better Accommodate Cell and Gene Therapies
2022 Industry Profile Toolkit: The Biopharmaceutical Research Ecosystem: The Role of NIH and Industry in the Research and Development of New Medicines
2022 The 340B Program Once a Safety Net Program Now a Program that Fails Vulnerable Patients
